Molecular Basis and Therapies in Neurological Disorders
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 25 June 2024 | Viewed by 121
Special Issue Editor
Interests: pediatric neurology; cerebral palsy; neurological disorders; biomarkers; Alzheimer's disease; Parkinson’s; stroke
Special Issue Information
Dear Colleagues,
The Special Issue "Molecular Basis and Therapies in Neurological Disorders" is a collection dedicated to exploring the molecular basis and treatments of neurological diseases.
The Special Issue covers the molecular mechanisms of various neurological diseases, including but not limited to Alzheimer's disease, Parkinson's disease, stroke, etc. In-depth research on the pathogenesis and molecular pathways of these diseases will provide the basis for the development of new treatments. This Special Issue focuses on the latest treatments for neurological diseases, including drug therapy, gene therapy, stem cell therapy, and more. Researchers and clinicians will share their experiences and results in developing new treatments. This Special Issue aims to provide the scientific community with an in-depth understanding of the latest research advances and treatment innovations in neurological diseases.
The Special Issue will include, but is not limited to, the following aspects:
- Research on molecular markers: Exploring potential biomarkers to support early diagnosis and personalized treatment.
- Gene editing in the treatment of neurological diseases: Assessing the promise and challenges of CRISPR and other gene editing technologies in treating neurological diseases.
- Nerve regeneration therapy: Exploring the potential role of stem cells and other regenerative medicine approaches in repairing damaged neural tissue.
All these efforts aim to improve neurological disorder management and consequently achieve a better quality of life for patients.
Dr. Mihaela-Adela Vinţan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurological diseases
- nerve damage
- Alzheimer's disease
- Parkinson’s
- stroke
- pathogenesis
- drug treatment
- nanomedicine delivery
- gene therapy
- stem cell therapy
- therapeutic targets
- nerve regeneration
- molecular markers
- gene editing technology
